Trial intelligence / Profile preview

Apple Cider Vinegar for Metabolic Effects of ADT in Metastatic Prostate Cancer

NCT05802121Phase 1Recruiting

Sponsor
Western University
Start
Jul 2025
Primary completion
Sep 2026
Countries
1
01

Overview

Phase 1, randomised, open-label trial (2 arms), sponsored by Western University. Primary endpoints: Fecal Akkermansia muciniphilia counts at 6 months and Side effects and tolerability at 3 months. Started Jul 2025; status: recruiting.

Beyond the preview

Go deeper on NCT05802121.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05802121.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call